v3.25.1
Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net loss $ (11,834,412) $ (7,652,341)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 355,689 348,512
Stock compensation 2,128,469 1,369,238
Stock consideration issued to vendor 233,000 0
Change in fair value of contingent consideration 117,005 108,609
Bad debt expense 393,225 593,664
Gain on expiration of accrued tax liability 0 (2,090,978)
Changes in operating assets and liabilities, net of amounts acquired or assumed in connection with acquisition:    
Accounts receivable (54,890) 269,094
Other receivables (863,405) (191,468)
Inventories (491,151) (885,299)
Prepaid expenses and other current assets 705,365 227,523
Long-term receivables 39,995 18,149
Accounts payable 210,870 195,528
Long-term payables (14,995) (29,833)
Accounts payable and accrued liabilities - related parties 5,991,166 (253,709)
Accrued liabilities (163,849) 2,277,287
Accrued payroll taxes, penalties and interest 0 35,242
Deferred revenue (228,436) 749,378
Net cash used in operating activities (3,476,354) (4,911,404)
Cash flows from investing activities:    
Purchase of property and equipment (299,355) (605,515)
Purchase of intangibles 0 (385,792)
Acquisition of business, net of cash 0 70,979
Net cash used in investing activities (299,355) (920,328)
Cash flows from financing activities:    
Proceeds from related party notes payable 1,854,380 7,320,324
Repayments of related party notes payable (428,924) (752,256)
Net proceeds (repayments) from notes payable 1,485,703 (1,077)
Proceeds from private placement 604,000 0
Net cash provided by financing activities 3,515,159 6,566,991
Net change in cash and cash equivalents (260,550) 735,259
Effect of exchange rate changes on cash 46,182 29,633
Cash and cash equivalents at beginning of period 812,806 772,062
Cash and cash equivalents at end of period 598,438 1,536,954
Supplemental disclosure of cash flow information:    
Cash paid for interest 114,626 0
Supplemental disclosure of non-cash investing and financing activities:    
Conversion of accounts payable-related parties to note payable-related parties 1,509,432
Common stock issued pursuant to business combination 70,936
Conversion of convertible note payable, accrued interest and premium into common stock 1,447,488
Increase (Decrease) in right-of-use asset and liability $ (30,751) $ 1,192,774